{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:49:55Z","timestamp":1793162995199,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008741","name":"EULAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ard.2025.01.028","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:07:50Z","timestamp":1744175270000},"page":"899-909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-7868","authenticated-orcid":false,"given":"Seza","family":"Ozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6542-2656","authenticated-orcid":false,"given":"Erdal","family":"Sa\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-7146","authenticated-orcid":false,"given":"Teresa","family":"Oton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8219-3720","authenticated-orcid":false,"given":"Ahmet","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-9877","authenticated-orcid":false,"given":"Cristiana","family":"Sieiro Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2852-8910","authenticated-orcid":false,"given":"Deniz","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-033X","authenticated-orcid":false,"given":"Fabian Nikolai","family":"Proft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-2498","authenticated-orcid":false,"given":"Helen J.","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-6598","authenticated-orcid":false,"given":"Jasmin","family":"Kuemmerle Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0704-1916","authenticated-orcid":false,"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuray Aktay","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-3117","authenticated-orcid":false,"given":"\u00d6mer","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-6868","authenticated-orcid":false,"given":"Sezin","family":"Y\u00fcce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8391-5446","authenticated-orcid":false,"given":"Shaye","family":"Kivity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-8854","authenticated-orcid":false,"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-7567","authenticated-orcid":false,"given":"Tamara","family":"Sarkisian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-9397","authenticated-orcid":false,"given":"Tilmann","family":"Kallinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1788-1898","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Hentgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-6254","authenticated-orcid":false,"given":"Yeliz","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-1652","authenticated-orcid":false,"given":"Yosef","family":"Uziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziv","family":"Yardeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-2551","authenticated-orcid":false,"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ard.2025.01.028_bib0001","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.3390\/ijms24119584","article-title":"An update on familial Mediterranean fever","volume":"24","author":"Lancieri","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.ard.2025.01.028_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11926-017-0670-8","article-title":"Autoinflammatory diseases with periodic fevers","volume":"19","author":"Sag","year":"2017","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.1016\/j.ard.2025.01.028_bib0003","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41584-024-01145-1","article-title":"The past 25 years in paediatric rheumatology: insights from monogenic diseases","volume":"20","author":"Ozen","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0004","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.01.028_bib0005","series-title":"Familial Mediterranean Fever","first-page":"81","article-title":"Epidemiology of FMF worldwide","author":"Cerrito","year":"2015"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0006","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/kead439","article-title":"Old paradigms and new concepts in familial Mediterranean fever (FMF): an update 2023","volume":"63","author":"Ben-Chetrit","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ard.2025.01.028_bib0007","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/rheumatology\/keaa863","article-title":"Defining colchicine resistance\/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach","volume":"60","author":"\u00d6zen","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.01.028_bib0008","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12969-023-00875-y","article-title":"Treat-to-target strategies for the management of familial Mediterranean Fever in children","volume":"21","author":"Ehlers","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0009","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/rheumatology\/kead514","article-title":"Efficacy and safety of anti-interleukin-1 treatment in familial Mediterranean fever patients: a systematic review and meta-analysis","volume":"63","author":"Kilic","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"10.1016\/j.ard.2025.01.028_bib0010","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/annrheumdis-2018-eular.5246","article-title":"Long-term efficacy and safety of canakinumab in patients with colchicineresistant FMF (CRFMF), traps and HIDS\/MKD: results from the pivotal phase 3 cluster trial","volume":"77","author":"De Benedetti","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.ard.2025.01.028_bib0011","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ard.2025.01.028_bib0012","series-title":"EULAR SOPs: Standard Operating Procedures for Task Forces [Internet]","year":"2024"},{"key":"10.1016\/j.ard.2025.01.028_bib0013","article-title":"Safety of colchicine on fertility, pregnancy, and lactation: a systematic review and metanalysis informing the EULAR\/PReS recommendations for familial Mediterranean fever","author":"Oton","year":"2024","journal-title":"TBC"},{"key":"10.1016\/j.ard.2025.01.028_bib0014","article-title":"Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR\/PReS recommendations for familial Mediterranean fever","author":"Sag","year":"2024","journal-title":"TBC"},{"key":"10.1016\/j.ard.2025.01.028_bib0015","article-title":"The Oxford Levels of Evidence 2 [Internet]","year":"2011","journal-title":"Oxford Centre for Evidence-Based Medicine"},{"issue":"11","key":"10.1016\/j.ard.2025.01.028_bib0016","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.revmed.2023.10.441","article-title":"French protocol for the diagnosis and management of familial Mediterranean fever","volume":"44","author":"Georgin-Lavialle","year":"2023","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ard.2025.01.028_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152211","article-title":"Adherence to colchicine prophylaxis among patients with familial Mediterranean fever treated with interleukin-1 inhibitors","volume":"61","author":"Levinsky","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ard.2025.01.028_bib0018","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/annrheumdis-2020-218986","article-title":"2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice","volume":"80","author":"Ritschl","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ard.2025.01.028_bib0019","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2014-206807","article-title":"EULAR recommendations for patient education for people with inflammatory arthritis","volume":"74","author":"Zangi","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.46497\/ArchRheumatol.2021.8215","article-title":"Familial Mediterranean fever: health-related quality of life and associated variables in a national cohort","volume":"36","author":"Bodur","year":"2021","journal-title":"Arch Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0021","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3906\/sag-2011-98","article-title":"Decreased exercise capacity, strength, physical activity level and quality of life in adult patients with familial Mediterranean fever","volume":"51","author":"Tore","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.ard.2025.01.028_bib0022","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00296-017-3882-3","article-title":"Ulutatar F. Fatigue in familial Mediterranean fever and its relations with other clinical parameters","volume":"38","author":"Duruoz","year":"2018","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.ard.2025.01.028_bib0023","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/mr\/roab070","article-title":"Investigating the lower extremity-related anaerobic exercise capacity and functional status in adult patients with familial Mediterranean fever","volume":"32","author":"Acar","year":"2022","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0024","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1097\/RHU.0000000000001710","article-title":"Comparison of anaerobic exercise capacity in children with familial Mediterranean fever and healthy controls","volume":"28","author":"Turkucar","year":"2022","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.24953\/turkjped.2023.122","article-title":"Assessing fatigue and related factors in adolescents with familial Mediterranean fever (FMF): psychometric properties of the PedsQL Multidimensional Fatigue Scale","volume":"65","author":"Sara\u00e7","year":"2023","journal-title":"Turk J Pediatr"},{"issue":"5","key":"10.1016\/j.ard.2025.01.028_bib0026","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00431-024-05442-5","article-title":"The assessment of fatigue and sleep quality among children and adolescents with familial Mediterranean fever: a case-control and correlation study","volume":"183","author":"\u0130ncesu","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"9","key":"10.1016\/j.ard.2025.01.028_bib0027","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/annrheumdis-2018-213585","article-title":"2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis","volume":"77","author":"Rausch Osthoff","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.01.028_bib0028","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/ard-2023-224514","article-title":"2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases","volume":"83","author":"Dures","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000713","article-title":"Effects of exercise and physical activity promotion: meta-analysis informing the 2018 EULAR recommendations for physical activity in people with rheumatoid arthritis, spondyloarthritis and hip\/knee osteoarthritis","volume":"4","author":"Rausch Osthoff","year":"2018","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.ard.2025.01.028_bib0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1756-185X.14315","article-title":"The effect of exercise training programs with aerobic components on C-reactive protein, erythrocyte sedimentation rate and self-assessed disease activity in people with ankylosing spondylitis: a systematic review and meta-analysis","volume":"25","author":"Harpham","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2025.01.028_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003350","volume":"9","author":"Santos","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.ard.2025.01.028_bib0032","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/keaa452","article-title":"Serum amyloid A1 genotype associates with adult-onset familial Mediterranean fever in patients homozygous for mutation M694V","volume":"60","author":"Kriegsh\u00e4user","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.ard.2025.01.028_bib0033","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrrheum.2013.174","article-title":"A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin","volume":"10","author":"Ozen","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ard.2025.01.028_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13075-016-0980-7","article-title":"Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever\u2013a randomized controlled noninferiority trial","volume":"18","author":"Polat","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.ard.2025.01.028_bib0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3906\/sag-2001-261","article-title":"Colchicine intolerance in FMF patients and primary obstacles for optimal dosing","volume":"50","author":"Sati\u015f","year":"2020","journal-title":"Turk J Med Sci"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0036","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial Mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.01.028_bib0037","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/art.38777","article-title":"Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study","volume":"66","author":"Brik","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"10.1016\/j.ard.2025.01.028_bib0038","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ard.2025.01.028_bib0039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.55563\/clinexprheumatol\/e92f7o","article-title":"Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial","volume":"39 Suppl 132","author":"Lachmann","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.ard.2025.01.028_bib0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.ard.2025.01.028_bib0041","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2020-217419","article-title":"Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial","volume":"79","author":"Ozen","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.01.028_bib0042","first-page":"1535","article-title":"A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever","volume":"40","author":"Koga","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"18","key":"10.1016\/j.ard.2025.01.028_bib0043","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.3390\/jcm11185360","article-title":"Tocilizumab for the treatment of familial mediterranean fever\u2014a randomized, double-blind, placebo-controlled phase II study","volume":"11","author":"Henes","year":"2022","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ard.2025.01.028_bib0044","first-page":"124","article-title":"Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy","volume":"35 Suppl 108","author":"S\u00f6nmez","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0045","first-page":"188","article-title":"Protracted febrile myalgia syndrome in a kidney transplant recipient with familial Mediterranean fever","volume":"13","author":"Abdel Halim","year":"2015","journal-title":"Exp Clin Transplant"},{"issue":"3","key":"10.1016\/j.ard.2025.01.028_bib0046","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/RHU.0000000000001271","article-title":"Protracted febrile myalgia syndrome treated with tocilizumab","volume":"27","author":"Honda","year":"2021","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2025.01.028_bib0047","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.semarthrit.2017.10.008","article-title":"Protracted febrile myalgia syndrome treated with pulse of corticosteroids","volume":"47","author":"Rom","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.01.028_bib0048","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00296-018-4163-5","article-title":"Protracted febrile myalgia as a challenging manifestation of familial Mediterranean fever: case-based review","volume":"39","author":"Y\u0131ld\u0131r\u0131m","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ard.2025.01.028_bib0049","article-title":"Long-term follow-up and optimization of interleukin-1 inhibitors in the management of monogenic autoinflammatory diseases: real-life data from the JIR cohort","volume":"11","author":"Hentgen","year":"2020","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0049-0172(91)90019-V","article-title":"Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years","volume":"20","author":"Ben-Chetrit","year":"1991","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ard.2025.01.028_bib0051","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2459\/JCM.0000000000001157","article-title":"Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials","volume":"22","author":"Andreis","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"6","key":"10.1016\/j.ard.2025.01.028_bib0052","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/liv.14445","article-title":"Non-amyloid liver involvement in familial Mediterranean fever: a systematic literature review","volume":"40","author":"Fraisse","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.ard.2025.01.028_bib0053","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/keaa811","article-title":"Could we measure hair colchicine to assess colchicine observance in familial Mediterranean fever?","volume":"60","author":"Georgin-Lavialle","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0054","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/rheumatology\/kead625","article-title":"Colchicine: the good, the bad, the ugly and how to minimize the risks","volume":"63","author":"Stamp","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10067-018-4230-z","article-title":"On demand use of anakinra for attacks of familial Mediterranean fever (FMF)","volume":"38","author":"Babaoglu","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.ard.2025.01.028_bib0056","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1093\/rheumatology\/keaa121","article-title":"Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry","volume":"59","author":"Sag","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ard.2025.01.028_bib0057","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/S0049-0172(03)00137-9","article-title":"Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization","volume":"33","author":"Lidar","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.01.028_bib0058","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2012.07.025","article-title":"Incomplete response to colchicine in M694V homozygote FMF patients","volume":"12","author":"Lidar","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0059","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2006-1434","article-title":"Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement","volume":"119","author":"Kallinich","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ard.2025.01.028_bib0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/03009742.2015.1127413","article-title":"Anakinra for the treatment of familial Mediterranean fever-associated spondyloarthritis","volume":"45","author":"Varan","year":"2016","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0061","doi-asserted-by":"crossref","first-page":"175","DOI":"10.24953\/turkjped.2020.02.002","article-title":"Sacroiliitis associated with familial Mediterranean fever in childhood: a case series and review of literature","volume":"62","author":"Y\u0131ld\u0131r\u0131m","year":"2020","journal-title":"Turk J Pediatr"},{"issue":"3","key":"10.1016\/j.ard.2025.01.028_bib0062","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40264-022-01265-1","article-title":"Colchicine drug interaction errors and misunderstandings: recommendations for improved evidence-based management","volume":"46","author":"Hansten","year":"2023","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.ard.2025.01.028_bib0063","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/rheumatology\/kead417","article-title":"Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis","volume":"63","author":"Hirahara","year":"2024","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:10:56Z","timestamp":1774415456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0003496725000846"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.01.028","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}